Quantbot Technologies’s Dyne Therapeutics DYN Stock Holding History

Quantbot Technologies’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,098	Closed	-$19.9K	–	1992
2026 Q1	$19.9K	Buy	+1,098	New	+$18.9K	﹤0.01%	1486
2025 Q4	–	Sell	-17,513	Closed	-$222K	–	1820
2025 Q3	$222K	Buy	+17,513	New	+$200K	0.01%	1261
2024 Q4	–	Sell	-959	Closed	-$34.4K	–	1566
2024 Q3	$34.4K	Buy	+959	New	+$38.2K	﹤0.01%	1319
2023 Q1	–	Sell	-400	Closed	-$4.64K	–	1676
2022 Q4	$4.64K	Buy	+400	New	+$4.63K	﹤0.01%	1559
2022 Q3	–	Sell	-2,100	Closed	-$14K	–	1703
2022 Q2	$14K	Sell	2,100 -800	-28%	-$5.51K	﹤0.01%	1493
2022 Q1	$27K	Sell	2,900 -100	-3%	-$851	﹤0.01%	1317
2021 Q4	$35K	Sell	3,000 -1,400	-32%	-$19.7K	﹤0.01%	1113
2021 Q3	$71K	Buy	+4,400	New	+$78K	0.01%	1045

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantbot Technologies's DYN Position: Q2 2026 in Review

Quantbot Technologies sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 1,098 shares — an estimated $19.9K sold.

Quantbot Technologies first reported a position in DYN in Q3 2021 and held it in 8 quarters. The position peaked at $222K in Q3 2025. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Quantbot Technologies reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 1,098 Dyne Therapeutics shares in Q2 2026, an estimated $19.9K.
Quantbot Technologies first reported a position in Dyne Therapeutics in Q3 2021 and held it in 8 quarters.
Quantbot Technologies's Dyne Therapeutics position peaked at $222K in Q3 2025.
246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.